About
Technology
Issues
FAQ
Links
Official Page
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.